
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1

<p xmlns="http://www.w3.org/1999/xhtml">
<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=d2ae426d030e37eae8312e34b33961e4" shape="rect">IQVIA</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IQV">IQV</a>), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1 in Everest Group’s "Top 50&#x2122; Pharmaceutical Technology Providers" report for 2026.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA earned the highest overall score among the 50 providers evaluated, receiving 96.8 out of 100. The ranking recognizes IQVIA’s broad technology coverage across the pharmaceutical value chain and its ability to support complex, highly regulated life sciences environments.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA was the only provider in the ranking with technology coverage across all six pharmaceutical value-chain areas assessed: drug discovery and research, clinical development, manufacturing operations, sales and marketing, supply chain and distribution and pharmacovigilance and safety.

</p><p xmlns="http://www.w3.org/1999/xhtml">
This breadth of coverage helps customers connect capabilities across the product lifecycle, make better decisions and execute more effectively. IQVIA combines proprietary data and content, deep life sciences expertise, advanced technology and longstanding experience operating in highly regulated, privacy-sensitive environments to help customers address complex challenges with greater confidence. Biopharma customers are looking for more than individual technologies. They demand solutions that work together and a partner that understands the realities of their business.

</p><p xmlns="http://www.w3.org/1999/xhtml">
To read the full Everest Group report, visit: "<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fiqvia.com%2FLibrary%2FPublications%2FIQVIA-ranked-1-in-Everest-Groups-Top-50-Pharmaceutical-Technology-Providers-2026&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=Top+50%26%238482%3B+Pharmaceutical+Technology+Providers&amp;index=2&amp;md5=e3c7138e9b91fda1597bcc41171137b7" shape="rect">Top 50&#x2122; Pharmaceutical Technology Providers</a>."

</p><p xmlns="http://www.w3.org/1999/xhtml">
To learn more about how IQVIA helps life sciences and healthcare organizations turn data, technology and AI into better outcomes, visit: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=3&amp;md5=b5ea7f70ee51cdf4b0f4bef08847461c" shape="rect">www.iqvia.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Everest Group</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Everest Group is a leading global research firm helping business leaders make confident decisions. It guides clients through today’s market challenges and strengthens their strategies by applying contextualized problem-solving to their unique situations. This drives maximized operational and financial performance and transformative experiences. The Everest Group’s deep expertise and tenacious research focused on technology, business processes and engineering through the lenses of talent, sustainability and sourcing deliver precise and action-oriented guidance. Find further details and in-depth content at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.everestgrp.com%2F&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.everestgrp.com&amp;index=4&amp;md5=1a4f842b247226d32db9c968638399fc" shape="rect">www.everestgrp.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About IQVIA</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IQV">IQV</a>) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence&#x2122; to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI<sup xmlns="http://www.w3.org/1999/xhtml">&#xAE;</sup>, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=5&amp;md5=4dbe216784a82113d6c1213acc4fc556" shape="rect">www.iqvia.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIAFIN

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260817167837r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260817167837/en/" rel="nofollow">https://www.businesswire.com/news/home/20260817167837/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Kerri Joseph, IQVIA Investor Relations (<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:kerri.joseph@iqvia.com" shape="rect">kerri.joseph@iqvia.com</a>)
<br xmlns="http://www.w3.org/1999/xhtml"></br>+1.973.541.3558

</p><p xmlns="http://www.w3.org/1999/xhtml">
Alissa Maupin, IQVIA Media Relations (<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:alissa.maupin1@iqvia.com" shape="rect">alissa.maupin1@iqvia.com</a>)
<br xmlns="http://www.w3.org/1999/xhtml"></br>+1.919.923.6785

</p>

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

IQVIA Tops Everest Group 2026 ranking with broad pharma tech coverage

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>IQVIA was named the top provider in Everest Group&#039;s 2026 Top 50 Pharmaceutical Technology Providers, posting a 96.8/100 score and the only vendor spanning all six pharmaceutical value-chain areas. The recognition underscores IQVIA&#039;s integrated platform and regulatory-savvy capabilities, potentially supporting longer-term client wins and cross-solution adoption, though no immediate financial metrics or guidance were disclosed.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>IQVIA ranked No.1 in Everest Group&#039;s Top 50 Pharmaceutical Technology Providers 2026.</li><li>IQVIA scored 96.8/100, highest among 50 evaluated providers.</li><li>Only provider with technology coverage across all six pharma value-chain areas.</li><li>Ranking highlights breadth across drug discovery to pharmacovigilance and safety.</li><li>Publication date: August 17, 2026; Everest Group emphasizes integrated solutions.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>IQVIA (IQV)</strong>: Ranked No.1; potential long-term branding and demand implications.</li><li><strong>Everest Group</strong>: Research firm; no direct financial impact or ticker; validates IQVIA&#039;s market position.</li></ul>
  </section>

  <section data-block="category">
    <h3>Industry News</h3>
    <p>Category: Industry News. It reinforces IQVIA&#039;s competitive positioning and breadth of capabilities, which could subtly influence long-term demand but is not an earnings catalyst by itself.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Positive Everest Group recognition could improve demand pipeline and client coverage over time.</li><li>No earnings guidance changes tied to this release; near-term price impact limited.</li><li>Broader, integrated platform might support longer-term multiple expansion if client wins occur.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>IQVIA ranked No.1 in Everest Group&#039;s Top 50 Pharmaceutical Technology Providers 2026.</li><li>Score: 96.8 out of 100 in the ranking.</li><li>IQVIA uniquely covers all six pharma value-chain areas.</li><li>Publication date: August 17, 2026.</li><li>Everest Group is a leading global research firm.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral-to-bullish over 6–12 months as branding gains may translate into demand, with limited near-term earnings impact.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=d2ae426d030e37eae8312e34b33961e4" shape="rect">IQVIA</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IQV">IQV</a>), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1 in Everest Group’s "Top 50&#x2122; Pharmaceutical Technology Providers" report for 2026.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA earned the highest overall score among the 50 providers evaluated, receiving 96.8 out of 100. The ranking recognizes IQVIA’s broad technology coverage across the pharmaceutical value chain and its ability to support complex, highly regulated life sciences environments.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA was the only provider in the ranking with technology coverage across all six pharmaceutical value-chain areas assessed: drug discovery and research, clinical development, manufacturing operations, sales and marketing, supply chain and distribution and pharmacovigilance and safety.

</p><p xmlns="http://www.w3.org/1999/xhtml">
This breadth of coverage helps customers connect capabilities across the product lifecycle, make better decisions and execute more effectively. IQVIA combines proprietary data and content, deep life sciences expertise, advanced technology and longstanding experience operating in highly regulated, privacy-sensitive environments to help customers address complex challenges with greater confidence. Biopharma customers are looking for more than individual technologies. They demand solutions that work together and a partner that understands the realities of their business.

</p><p xmlns="http://www.w3.org/1999/xhtml">
To read the full Everest Group report, visit: "<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fiqvia.com%2FLibrary%2FPublications%2FIQVIA-ranked-1-in-Everest-Groups-Top-50-Pharmaceutical-Technology-Providers-2026&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=Top+50%26%238482%3B+Pharmaceutical+Technology+Providers&amp;index=2&amp;md5=e3c7138e9b91fda1597bcc41171137b7" shape="rect">Top 50&#x2122; Pharmaceutical Technology Providers</a>."

</p><p xmlns="http://www.w3.org/1999/xhtml">
To learn more about how IQVIA helps life sciences and healthcare organizations turn data, technology and AI into better outcomes, visit: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=3&amp;md5=b5ea7f70ee51cdf4b0f4bef08847461c" shape="rect">www.iqvia.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Everest Group</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Everest Group is a leading global research firm helping business leaders make confident decisions. It guides clients through today’s market challenges and strengthens their strategies by applying contextualized problem-solving to their unique situations. This drives maximized operational and financial performance and transformative experiences. The Everest Group’s deep expertise and tenacious research focused on technology, business processes and engineering through the lenses of talent, sustainability and sourcing deliver precise and action-oriented guidance. Find further details and in-depth content at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.everestgrp.com%2F&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.everestgrp.com&amp;index=4&amp;md5=1a4f842b247226d32db9c968638399fc" shape="rect">www.everestgrp.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About IQVIA</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IQV">IQV</a>) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence&#x2122; to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI<sup xmlns="http://www.w3.org/1999/xhtml">&#xAE;</sup>, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com&amp;esheet=54589628&amp;newsitemid=20260817167837&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=5&amp;md5=4dbe216784a82113d6c1213acc4fc556" shape="rect">www.iqvia.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
IQVIAFIN

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260817167837r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260817167837/en/" rel="nofollow">https://www.businesswire.com/news/home/20260817167837/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Kerri Joseph, IQVIA Investor Relations (<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:kerri.joseph@iqvia.com" shape="rect">kerri.joseph@iqvia.com</a>)
<br xmlns="http://www.w3.org/1999/xhtml"></br>+1.973.541.3558

</p><p xmlns="http://www.w3.org/1999/xhtml">
Alissa Maupin, IQVIA Media Relations (<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:alissa.maupin1@iqvia.com" shape="rect">alissa.maupin1@iqvia.com</a>)
<br xmlns="http://www.w3.org/1999/xhtml"></br>+1.919.923.6785

</p>

IQVIA was named the top provider in Everest Group's 2026 Top 50 Pharmaceutical Technology Providers, posting a 96.8/100 score and the only vendor spanning all six pharmaceutical value-chain areas. The recognition underscores IQVIA's integrated platform and regulatory-savvy capabilities, potentially supporting longer-term client wins and cross-solution adoption, though no immediate financial metrics or guidance were disclosed.

News insight

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

AI summary

Sentiment rationale

Key facts

Industry News